Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-23-007304

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Howe Jill Ann · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-09 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X03/ownership.xml…